ClinVar Miner

Submissions for variant NM_000059.4(BRCA2):c.7535T>C (p.Leu2512Pro)

dbSNP: rs1593919683
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV001026534 SCV001188935 uncertain significance Hereditary cancer-predisposing syndrome 2019-03-20 criteria provided, single submitter clinical testing The p.L2512P variant (also known as c.7535T>C), located in coding exon 14 of the BRCA2 gene, results from a T to C substitution at nucleotide position 7535. The leucine at codon 2512 is replaced by proline, an amino acid with similar properties. This variant was detected in 1/117 Turkish individuals diagnosed with breast cancer and the authors reported this as a neutral/polymorphism finding (Cecener G et al. Cancer Invest. 2014 Oct;32:375-87). This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.